Serum miRNA-29b levels were independent of tumor-related factors such as proliferative activity according to Ki-67 index, tumor classification, TMN stage of malignant tumors, somatostatin receptor expression or clinical features such as functional or non-functional disease and the presence of tumor recurrence. This evidence concerns the gene MKI67 and neoplasm.